Castleark Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,560
Closed -$1.72M 329
2022
Q3
$1.72M Buy
+24,560
New +$1.72M 0.1% 165
2021
Q1
Sell
-25,918
Closed -$5.69M 381
2020
Q4
$5.69M Sell
25,918
-20,510
-44% -$4.51M 0.21% 129
2020
Q3
$7.71M Sell
46,428
-132
-0.3% -$21.9K 0.3% 101
2020
Q2
$5.32M Sell
46,560
-520
-1% -$59.4K 0.23% 118
2020
Q1
$3.62M Buy
+47,080
New +$3.62M 0.21% 127